Iván Galván‐Femenía

High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial

Andrea Alemany, Pere Millat-Martínez, Marc Corbacho‐Monné et al. · The Lancet Respiratory Medicine · 2022 · 84 citations · Full text

Covid-19 Pandemic, Clinical Trials, Treatment Option +5

GCAT|Genomes for life: a prospective cohort study of the genomes of Catalonia

Mireia Obón‐Santacana, Mireia Vilardell, Anna Carreras et al. · BMJ Open · 2018 · 70 citations · Full text

ADAR1 function affects HPV replication and is associated to recurrent human papillomavirus-induced dysplasia in HIV coinfected individuals

Maria Pujantell, Roger Badía, Iván Galván‐Femenía et al. · Scientific Reports · 2019 · 70 citations · Full text

SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues

Matteo D’Antonio, Jennifer Nguyen, Timothy D. Arthur et al. · Cell Reports · 2021 · 46 citations · Full text

The chromatin network helps prevent cancer-associated mutagenesis at transcription-replication conflicts

Aleix Bayona‐Feliú, Emilia Herrera‐Moyano, Iván Galván‐Femenía et al. · Nature Communications · 2023 · 46 citations · Full text